US Patent Issued to Sana Biotechnology on Aug. 25 for "Methods and compositions for modulating CAR-T activity" (California, Washington, Colorado Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,918, issued on Aug. 25, was assigned to Sana Biotechnology Inc. (Seattle).

"Methods and compositions for modulating CAR-T activity" was invented by Sonja Schrepfer (San Mateo, Calif.), Lindong Weng (Seattle) and Terry James Fry (Denver).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are engineered cells and/or hypoimmunogenic cells including engineered and/or hypoimmunogenic stem cells, engineered and/or hypoimmunogenic cells differentiated therefrom, engineered and/or hypoimmunogenic CAR-T cells (primary or differentiated from engineered and/or hypoimmunogenic stem cells) and related methods of their use and generation. Provided her...